A growing portfolio of in vivo-ready bispecific antibodies provides immediate access to anti-mouse and anti-human dual-target ...
Because the antibodies are so selective for beta cells, the treatment appears to be safe for long-term use with few side effects, the team says. At this stage, the study has only been conducted in ...
Antibody humanization involves modifying antibodies from non-human sources, such as mice, to decrease their immunogenicity in human applications. While mouse monoclonal antibodies are specific, they ...
Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of ...
A study conducted in mice by researchers in the lab of Irvine Weissman, MD, at Stanford University School of Medicine, and at the National Institutes of Health’s Rocky Mountain Laboratories, has ...
Monoclonal antibodies – treatments developed by cloning a cell that makes an antibody – could help provide an answer to the growing problem of antimicrobial resistance, say scientists. A team lead by ...
New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers at UZH have now developed a technology that can be used to test around 25 antibodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results